Angewandte
Chemie
DOI: 10.1002/anie.200906341
Radiofluorination
Fast Production of Highly Reactive No-Carrier-Added [18F]Fluoride
for the Labeling of Radiopharmaceuticals**
Christian F. Lemaire,* Joꢀl J. Aerts, Samuel Voccia, Lionel C. Libert, Frꢁdꢁric Mercier,
David Goblet, Alain R. Plenevaux, and Andrꢁ J. Luxen
Fluorine-18 has become the most widely used short-lived
radioisotope for the labeling of radiopharmaceuticals for
positron emission tomography (PET; 18F, t1/2 = 109.7 min).[1]
Depending on the mode of production, the no-carrier-added
[18F]fluoride ion can be obtained in aqueous solution. How-
ever, under these conditions it is strongly hydrated and
therefore unreactive for nucleophilic substitution. Several
methods have been developed to increase its reactivity.[2,3]
Currently, the most well-established procedure requires
trapping of the [18F]fluoride ion on an anion-exchange resin
and its subsequent elution with a small volume of an organic–
aqueous solution (CH3CN/H2O, 50:50 v/v) of an inorganic
weak base (potassium carbonate) and a cryptand (kryptofix
K222).[4] After two or three azeotropic evaporation steps, the
cryptand enables solubilization of the [18F]fluoride ion in an
active form in a polar aprotic solvent suitable for the
subsequent labeling reaction (e.g. CH3CN, dimethyl sulfox-
ide). However, this process, which requires several minutes
(5–10 min) and complex automation, consumes radiochem-
ical yield (3.1–6.1%) and is not suited to the miniaturization
of PET equipment.
considered as the main limitation to the size reduction of such
systems.
Herein, we evaluate a new method for elution from the
anion-exchange resin which would avoid the aforementioned
azeotropic evaporation step with acetonitrile. This step is
typically very difficult to implement on a microchip device.
We examined a selection of organic bases as potential
additives to replace the inorganic bases or salts classically
used in the resin eluent.
A large variety of organic bases that differ, for example, in
terms of strength, nucleophilicity, and steric hindrance, are
commercially available (some are listed in Table 1 according
to their pKa value). These organic bases usually contain
nitrogen atoms, the protonation of which can lead to highly
reactive anions.[7]
Table 1: Effect of the nature of the base on the radiochemical yield of 2.[a]
Entry
Base
pKa[b]
RY[c] [%]
Water[d] [ppm]
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
none
Et3N
sparteine
TMG
BTMG
DBN
–
15
30
25
27
95
13
47
87
93
22
81
93
92
76
17
14
6
4958
2392
2912
1746
3912
6641
3572
2621
4755
4899
3543
2748
446
18.46
21.66
23.3
23.56
23.89
24.3
25.1
25.44
25.98
26.5
26.9
27.6
28.4
32.9
32.9
41.9
As an example, the synthesis of [18F]fluorodeoxyglucose
(FDG), the most used PET metabolic tracer, with micro-
reactors or microfluidic chips was recently reported.[5] The
extremely high surface-area-to-volume ratio of these micro-
reactors enables experiments to be performed on a far lower
scale than is possible with conventional-scale reactors; lower
starting amounts of very expensive precursors are required,
the products are purer and obtained in higher yield and in
shorter reaction times, and there is less waste. Moreover, hot-
cell shielding is greatly facilitated. However, despite all these
advantages, the [18F]fluoride is always dried by the conven-
tional method with K2CO3.[6] This unavoidable step can be
DBU
TMGN
MTBD
TBD
P1tOct
P1tBu
BEMP
BTPP
P2Et
Verkade iPr
P4tBu
3877
3536
1960
2720
[a] Reaction conditions: 1a (40 mg), CH3CN (1 mL), solution of 18FÀ
(20 mL), base (50 mmol), 1008C, 5 min. [b] pKa value of the conjugate
acid in CH3CN. [c] Radiochemical yield (decay-corrected). [d] Water
content after labeling. BEMP=2-tert-butylimino-2-diethylamino-1,3-
dimethylperhydro-1,3,2-diazaphosphorine, BTMG=2-tert-butyl-1,1,3,3-
tetramethylguanidine, BTPP=tert-butylimino-tri(pyrrolidino)phosphor-
ane, DBN=1,5-diazabicyclo[4.3.0]non-5-ene, DBU=1,8-diazabicyclo-
[5.4.0]undec-7-ene, TMG=1,1,3,3-tetramethylguanidine, MTBD=7-
methyl-1,5,7-triazabicyclo[4.4.0]dec-5-ene, P1tBu=tert-butylimino-tris-
[*] Dr. C. F. Lemaire, Dr. J. J. Aerts, L. C. Libert, Dr. F. Mercier, D. Goblet,
Dr. A. R. Plenevaux, Prof. A. J. Luxen
University of Liꢀge, B30—Cyclotron Research Center
Sart Tilman, 4000 Liꢀge (Belgium)
Fax: (+32)4-366-2946
E-mail: christian.lemaire@ulg.ac.be
Dr. S. Voccia
Trasis sa
Voie de Liꢀge, 2, 4053 Embourg (Belgium)
(dimethylamino)phosphorane,
P1tOct=tert-octylimino-tris(dimethyl-
amino)phosphorane, P1tBu=tert-butylimino-tris(dimethylamino)phos-
phorane, P2Et=N’’’-ethyl-N,N,N’,N’-tetramethyl-N’’-[tris(dimethylami-
no)phosphoranylidene]phosphorimidic triamide, P4tBu=N-[[tert-butyl-
imino-bis[tris(dimethylamino)phosphoranylideneamino]phosphoranyl]-
imino-bis(dimethylamino)phosphoranyl]-N-methylmethanamine, TBD=
1,5,7-triazabicyclo[4.4.0]dec-5-ene, TMGN=1,8-bis(tetramethylguani-
dino)naphtalene, Verkade iPr=2,8,9-triisopropyl-2,5,8,9-tetraaza-1-
phosphabicyclo[3.3.3]undecane.
[**] This project was supported by the Fonds de la Recherche
Scientifique, the University of Liꢀge (Fonds spꢁciaux, Crꢁdit
classique, and Fonds Rahier). A.R.P. is a Senior Research Associate
of the Fonds de la Recherche Scientifique (F.R.S.–FNRS, Brussels,
Belgium).
Supporting information for this article is available on the WWW
Angew. Chem. Int. Ed. 2010, 49, 3161 –3164
ꢀ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
3161